Exelon Corporation (EXC) — Fair Value Analysis

Base-case fair value (P50): $47.85 · Current price: $44.96 · Verdict: Fairly Valued

The Verdict on EXC

Based on our Monte Carlo simulations, Exelon (EXC) is currently assessed as Fairly Valued. Trading at $44.96, EXC shows a potential +6.4% upside to our median fair value (P50) of $47.85. This assessment suggests that while there is some headroom, the stock's current price largely reflects its intrinsic value, with less compelling undervaluation than opportunities found elsewhere. Our analysis, which models thousands of forward-looking scenarios, points to a balanced risk/reward profile at these levels, aligning with its "Fairly Valued" status.

How EXC stacks up against Utilities

Exelon's operational and financial health is categorized as average when compared to the broader Utilities sector. This quality tier implies that while EXC demonstrates stability inherent to utilities, it doesn't present significant competitive advantages or superior financial metrics relative to its peers. This average standing contributes to our "Fairly Valued" assessment, where the stock's current valuation of $44.96 is consistent with an entity of its quality, offering a projected +6.4% towards its median fair value of $47.85. For investors seeking deep discounts, an average quality utility at its fair value might not offer the most attractive entry point, though its stability can appeal to certain portfolio strategies.

What this means for investors

For investors, the "Fairly Valued" verdict on Exelon (EXC), coupled with its average quality tier, suggests a balanced outlook at $44.96. While there's a modest +6.4% to our P50 fair value of $47.85, significant undervaluation is not present. This implies that while EXC may offer predictable returns characteristic of the Utilities sector, it is unlikely to deliver outsized alpha without a substantial shift in its operational profile or market sentiment. Our Monte Carlo simulations account for both upside and downside scenarios, but currently, the weighted probabilities point to the stock trading near its intrinsic worth. Through our FairCurve analysis, investors can gain a clearer understanding of the full risk/reward spectrum. To explore the detailed bear and bull case distribution and track EXC's fair value as new fundamentals are released, sign up for FairCurve.

Frequently Asked Questions

Is EXC overvalued or undervalued right now?

Based on our Monte Carlo simulations, Exelon (EXC) is currently assessed as Fairly Valued. Its current price of $44.96 is close to our median fair value (P50) of $47.85, indicating it trades near its intrinsic worth.

What is the bear case and bull case for EXC?

Our full Monte Carlo distribution, including specific bear (P10) and bull (P90) target prices, along with the probability of upside, is exclusively available to users with a free FairCurve account. This comprehensive view provides deeper insights into potential scenarios for EXC.

How does FairCurve calculate EXC's fair value?

FairCurve calculates Exelon's fair value using sophisticated Monte Carlo simulations, modeling thousands of forward-looking financial scenarios. This robust approach provides a probabilistic estimate of intrinsic value, reflecting various market and operational uncertainties.

How can I track EXC's fair value as it changes?

You can easily track EXC's fair value by adding it to a free FairCurve watchlist. Our platform provides daily fair value updates and instantly re-evaluates the stock when new earnings or significant fundamental news are released.